SCHEMBL30349528

SCHEMBL30349528

Cc1c(C)c(C)c(-c2cccnc2)c(OC(C)(C)C(=O)O)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC22A12 Q96S37 1/20 0.43
▸ MKNK1 Q9BUB5 4/20 0.39
▸ MKNK2 Q9HBH9 4/20 0.39
▸ PPARA Q07869 3/20 0.39
▸ PPARG P37231 2/20 0.39
▸ GPR35 Q9HC97 2/20 0.39
▸ TSHR P16473 2/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ KMO O15229 1/20 0.38
▸ CDC7 O00311 1/20 0.37
▸ DBF4 Q9UBU7 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KIF11 P52732 1/20 0.37
▸ PPARD Q03181 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CYP2A6 P11509 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17899836 0.73 SLC22A12 (0.55) SLC22A12PPARAPPARGKDM4EHTT
SCHEMBL3372165 0.72 PPARA (0.50) SLC22A12PPARAPPARGTSHRKDM4E
SCHEMBL31359592 0.69 CYP2A6 (0.50) KDM4EHTTHSD17B10ALDH1A1CYP2A6
SCHEMBL10924024 0.67 CYP3A4 (0.44) MKNK1MKNK2KDM4EKMOHTT
SCHEMBL20255018 0.66 LMNA (0.46) MKNK1MKNK2PPARAKDM4EKMO
SCHEMBL23871139 0.65 PPARA (0.55) PPARAPPARGKDM4EHSD17B10PPARD
Pivalate SCHEMBL27910502 0.64 CYP2A6 (0.50) SLC22A12MKNK1MKNK2KMOKIF11
SCHEMBL11063546 0.64 PPARA (0.56) PPARAPPARG
SCHEMBL23830218 0.64 MKNK1 (0.46) MKNK1MKNK2GPR35KDM4EKMO
SCHEMBL14327641 0.64 CYP2A6 (0.52) MKNK1MKNK2KDM4EHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4178672-A1 MODULATORS OF THR-ß AND METHODS OF USE THEREOF Aligos Therapeutics, Inc. (US) 2023-05-17 — — EP disclosed
Send feedback